Primary Chemotherapy With Adriamycin/Cyclophosphamide(AC) vs Taxotere/Xeloda(TX) for Stage II and III Breast Cancer
Status:
Completed
Trial end date:
2006-01-01
Target enrollment:
Participant gender:
Summary
This is an open labeled phase III randomized trial. The patients with clinical stage II and
III will undergo mammotome biopsy of breast tumor for histologic diagnosis,
immunohistochemical studies for estrogen receptor(ER), progesterone receptor(PR), HER-2/neu
and others. PET results will determine the positivity of lymph node metastasis.